178 related articles for article (PubMed ID: 16873793)
1. Deficiencies of cardiovascular risk prediction models for type 1 diabetes.
Zgibor JC; Piatt GA; Ruppert K; Orchard TJ; Roberts MS
Diabetes Care; 2006 Aug; 29(8):1860-5. PubMed ID: 16873793
[TBL] [Abstract][Full Text] [Related]
2. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
Metcalf PA; Wells S; Scragg RK; Jackson R
N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
[TBL] [Abstract][Full Text] [Related]
3. Recalculation of cardiovascular risk score as a surrogate marker of change in clinical care of diabetes patients: the Alphabet POEM project (Practice Of Evidence-based Medicine).
Lee JD; Morrissey JR; Patel V;
Curr Med Res Opin; 2004 May; 20(5):765-72. PubMed ID: 15140344
[TBL] [Abstract][Full Text] [Related]
4. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study.
Guzder RN; Gatling W; Mullee MA; Mehta RL; Byrne CD
Diabet Med; 2005 May; 22(5):554-62. PubMed ID: 15842509
[TBL] [Abstract][Full Text] [Related]
6. Relation between age and coronary heart disease (CHD) risk in Asian Indian patients with diabetes: A cross-sectional and prospective cohort study.
Idris I; Deepa R; Fernando DJ; Mohan V
Diabetes Res Clin Pract; 2008 Aug; 81(2):243-9. PubMed ID: 18495288
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the performance of the Framingham risk equations in a population with diabetes.
McEwan P; Williams JE; Griffiths JD; Bagust A; Peters JR; Hopkinson P; Currie CJ
Diabet Med; 2004 Apr; 21(4):318-23. PubMed ID: 15049932
[TBL] [Abstract][Full Text] [Related]
8. Markers of endothelial dysfunction in the prediction of coronary artery disease in type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study.
Costacou T; Lopes-Virella MF; Zgibor JC; Virella G; Otvos J; Walsh M; Orchard TJ
J Diabetes Complications; 2005; 19(4):183-93. PubMed ID: 15993351
[TBL] [Abstract][Full Text] [Related]
9. Prediction of 10-year coronary heart disease risk in Caribbean type 2 diabetic patients using the UKPDS risk engine.
Ezenwaka CE; Nwagbara E; Seales D; Okali F; Hussaini S; Raja B; Jones-LeCointe A; Sell H; Avci H; Eckel J
Int J Cardiol; 2009 Mar; 132(3):348-53. PubMed ID: 18191239
[TBL] [Abstract][Full Text] [Related]
10. [Coronary risk assessment in subjects with type 2 diabetes mellitus. General population-based scores or specific scores?].
Hernáez R; Choque L; Giménez M; Costa A; Márquez JI; Conget I
Rev Esp Cardiol; 2004 Jun; 57(6):577-80. PubMed ID: 15225505
[TBL] [Abstract][Full Text] [Related]
11. Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation.
Ferrario M; Chiodini P; Chambless LE; Cesana G; Vanuzzo D; Panico S; Sega R; Pilotto L; Palmieri L; Giampaoli S;
Int J Epidemiol; 2005 Apr; 34(2):413-21. PubMed ID: 15659467
[TBL] [Abstract][Full Text] [Related]
12. Erectile dysfunction predicts coronary heart disease in type 2 diabetes.
Ma RC; So WY; Yang X; Yu LW; Kong AP; Ko GT; Chow CC; Cockram CS; Chan JC; Tong PC
J Am Coll Cardiol; 2008 May; 51(21):2045-50. PubMed ID: 18498959
[TBL] [Abstract][Full Text] [Related]
13. Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study.
Cheung N; Wang JJ; Klein R; Couper DJ; Sharrett AR; Wong TY
Diabetes Care; 2007 Jul; 30(7):1742-6. PubMed ID: 17389333
[TBL] [Abstract][Full Text] [Related]
14. Validity of the Framingham point scores in the elderly: results from the Rotterdam study.
Koller MT; Steyerberg EW; Wolbers M; Stijnen T; Bucher HC; Hunink MG; Witteman JC
Am Heart J; 2007 Jul; 154(1):87-93. PubMed ID: 17584559
[TBL] [Abstract][Full Text] [Related]
15. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
Levitzky YS; Pencina MJ; D'Agostino RB; Meigs JB; Murabito JM; Vasan RS; Fox CS
J Am Coll Cardiol; 2008 Jan; 51(3):264-70. PubMed ID: 18206734
[TBL] [Abstract][Full Text] [Related]
16. Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study.
Buyken AE; von Eckardstein A; Schulte H; Cullen P; Assmann G
Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):230-6. PubMed ID: 17446801
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study.
Davis WA; Colagiuri S; Davis TM
Med J Aust; 2009 Feb; 190(4):180-4. PubMed ID: 19220181
[TBL] [Abstract][Full Text] [Related]
18. Prediction of first events of coronary heart disease and stroke with consideration of adiposity.
Wilson PW; Bozeman SR; Burton TM; Hoaglin DC; Ben-Joseph R; Pashos CL
Circulation; 2008 Jul; 118(2):124-30. PubMed ID: 18591432
[TBL] [Abstract][Full Text] [Related]
19. Ten-year risk prediction in French men using the Framingham coronary score: results from the national SU.VI.MAX cohort.
Vergnaud AC; Bertrais S; Galan P; Hercberg S; Czernichow S
Prev Med; 2008 Jul; 47(1):61-5. PubMed ID: 18456313
[TBL] [Abstract][Full Text] [Related]
20. Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location.
Avogaro A; Giorda C; Maggini M; Mannucci E; Raschetti R; Lombardo F; Spila-Alegiani S; Turco S; Velussi M; Ferrannini E;
Diabetes Care; 2007 May; 30(5):1241-7. PubMed ID: 17290034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
